N/A N=69 Randomized Single-blind Treatment

Cognitive Training for Patients With Schizophrenia

Schizophrenia · Schizoaffective Disorder · Other Primary Psychotic Disorders

Bottom Line

View on ClinicalTrials.gov: NCT01521026 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Dec 2013

Primary outcome: Primary: UCSD Performance-based Skills Assessment Total Score (Measures Functional Capacity) — 82.7; 84.4 units on a scale

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Cognitive Training (Behavioral)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: University of California, San Diego
Primary completion: Aug 2009

Outcome Measures

Outcome	Result	p-value
PRIMARY UCSD Performance-based Skills Assessment Total Score (Measures Functional Capacity)	82.7; 84.4	—
SECONDARY Hopkins Verbal Learning Test Percent Retained	93.4; 85.9	—

Summary

This research on cognitive training addresses the following questions: 1. Does cognitive training lead to improved cognition, functional abilities, psychiatric symptoms, treatment adherence, or quality of life in patients with psychoses? 2. What are the neurocognitive and non-cognitive factors that predict good outcomes following cognitive rehabilitation? In addition to verbal learning and memory, immediate verbal memory, vigilance, and executive functioning, the cognitive training intervention attempted to improve prospective memory ability (i.e., the ability to remember to do things in the future, such as take medications or attend a doctor's appointment).

Eligibility Criteria

Inclusion Criteria

Primary psychotic disorder (including schizophrenia, schizoaffective disorder, psychotic mood disorder, or psychosis NOS)
Age 18 or older
Fluency in English

Exclusion Criteria

Dementia
Neurological conditions affecting cognition
Mental retardation
Substance use disorder within the past month
Participation in other intervention trials

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01521026). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.